Active ingredientLeuprorelinCat. No. P-L041-001CAS 53714-56-0Family · Pharmaceutical analytical standards
Leuprorelin
A synthetic analogue of the hypothalamic hormone GnRH made of nine amino acids, patented in 1973 and approved in the United States in 1985 for prostate cancer; it is also used for endometriosis, uterine fibroids and early puberty. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It works by paradox: at first it stimulates the pituitary gland and sex hormones rise, but with continuous dosing the receptors become desensitised and hormone production shuts down.
Go to the active ingredient →Active ingredientLeuprorelinCat. No. P-L041-001CAS 53714-56-0
Pharmacopoeial impurityLeuprolide EP Impurity A (TFA Salt)Cat. No. P-L041-006
Pharmacopoeial impurityLeuprolide EP Impurity B (TFA Salt)Cat. No. P-L041-007
Pharmacopoeial impurityLeuprolide EP Impurity C (TFA Salt)Cat. No. P-L041-008
Pharmacopoeial impurityLeuprolide EP Impurity D (TFA Salt)Cat. No. P-L041-009
Pharmacopoeial impurityLeuprolide EP Impurity DCat. No. P-L041-010CAS 1926163-25-8
Pharmacopoeial impurityLeuprolide EP Impurity F (TFA Salt)Cat. No. P-L041-012
Pharmacopoeial impurityLeuprolide EP Impurity G (TFA Salt)Cat. No. P-L041-013
Pharmacopoeial impurityLeuprorelin EP Impurity ACat. No. P-L041-018CAS 62621-13-0
Pharmacopoeial impurityLeuprorelin EP Impurity BCat. No. P-L041-020CAS 112642-11-2
Pharmacopoeial impurityLeuprorelin EP Impurity B DitrifluoroacetateCat. No. P-L041-021
Pharmacopoeial impurityLeuprorelin EP Impurity CCat. No. P-L041-022CAS 54785-87-4
Pharmacopoeial impurityLeuprorelin EP Impurity C DitrifluoroacetateCat. No. P-L041-023
Pharmacopoeial impurityLeuprorelin EP Impurity ECat. No. P-L041-025CAS 1926163-23-6
Pharmacopoeial impurityLeuprorelin EP Impurity FCat. No. P-L041-027CAS 1872435-00-1
Pharmacopoeial impurityLeuprorelin EP Impurity GCat. No. P-L041-029CAS 112710-57-3
Pharmacopoeial impurityLeuprorelin EP Impurity HCat. No. P-L041-031CAS 112710-58-4
Pharmacopoeial impurityLeuprorelin EP Impurity ICat. No. P-L041-033CAS 1926163-26-9
Pharmacopoeial impurityLeuprorelin EP Impurity I DitrifluoroacetateCat. No. P-L041-034
Impurity5-9-Leuprorelin DitrifluoroacetateCat. No. P-L041-038
Active ingredientLeuprorelin AcetateCat. No. P-L041-039CAS 88793-81-1
ImpurityLeuprorelin Impurity 1 TrifluoroacetateCat. No. P-L041-041
ImpurityLeuprorelin Impurity 2Cat. No. P-L041-042
ImpurityLeuprorelin Impurity 3Cat. No. P-L041-044
ImpurityLeuprorelin Impurity 4Cat. No. P-L041-045
ImpurityLeuprorelin Impurity 5Cat. No. P-L041-046
ImpurityLeuprorelin Impurity 6Cat. No. P-L041-047
ImpurityLeuprorelin Impurity 7Cat. No. P-L041-048
ImpurityLeuprorelin Impurity 8Cat. No. P-L041-049
ImpurityLeuprorelin Impurity 9Cat. No. P-L041-050
ImpurityLeuprorelin Impurity 10Cat. No. P-L041-051CAS 212388-38-0No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceLeuprorelin CRSEDQM code L0376000Family LeuprorelinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.